Top Markets
Coin of the day
Foresee Pharmaceuticals Co., Ltd. Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

6576
Classement en actions #14589
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Prix de l'action
$2.58
Capitalisation boursière
$405.78M
Changement (1 jour)
-0.25%
Changement (1 an)
1.54%
Pays
TW
Échange Foresee Pharmaceuticals Co., Ltd. (6576)

Catégorie

Ratio P/B pour Foresee Pharmaceuticals Co., Ltd. (6576)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Foresee Pharmaceuticals Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Foresee Pharmaceuticals Co., Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes